In two asthma mouse models, activation of PP2A reduced the severity of acute and chronic allergic airway disease by suppressing tissue eosinophils and inflammation, mucus-secreting cell numbers, IL-33, thymic stromal lymphopoietin, IL-5, IL-13, serum IgE, and airway hyper-responsiveness [118]. Here, PTPA is linked to asthma.